Insider Transactions in Q1 2022 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2022
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,187
+4.19%
|
$73,122
$6.28 P/Share
|
|
Feb 16
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
1,956
-100.0%
|
$84,108
$43.81 P/Share
|
|
Feb 15
2022
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
9,136
-3.32%
|
$392,848
$43.47 P/Share
|
|
Feb 15
2022
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,219
-0.44%
|
$53,636
$44.01 P/Share
|
|
Feb 15
2022
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,153
+1.48%
|
-
|
|
Feb 15
2022
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
323
-1.06%
|
$14,212
$44.01 P/Share
|
|
Feb 15
2022
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
923
+2.93%
|
-
|
|
Feb 15
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
780
-2.52%
|
$34,320
$44.01 P/Share
|
|
Feb 15
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,846
+5.62%
|
-
|
|
Feb 15
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
488
-0.3%
|
$21,472
$44.01 P/Share
|
|
Feb 15
2022
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,661
+1.03%
|
-
|
|
Feb 15
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
272
-1.19%
|
$11,968
$44.01 P/Share
|
|
Feb 15
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
923
+3.89%
|
-
|
|
Feb 15
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
2,278
-1.07%
|
$100,232
$44.01 P/Share
|
|
Feb 15
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
4,614
+2.13%
|
-
|
|
Feb 15
2022
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
813
-2.45%
|
$35,772
$44.01 P/Share
|
|
Feb 15
2022
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,769
+7.69%
|
-
|
|
Feb 15
2022
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,186
-0.39%
|
$360,184
$44.01 P/Share
|
|
Feb 15
2022
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,457
+0.87%
|
-
|
|
Feb 15
2022
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
326
-1.02%
|
$14,344
$44.01 P/Share
|
|
Feb 15
2022
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,108
+3.35%
|
-
|
|
Feb 15
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
622
-0.46%
|
$27,368
$44.01 P/Share
|
|
Feb 15
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,030
+1.48%
|
-
|
|
Feb 15
2022
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
259
-0.88%
|
$11,396
$44.01 P/Share
|
|
Feb 15
2022
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
738
+2.44%
|
-
|
|
Feb 15
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
575
-0.33%
|
$25,300
$44.01 P/Share
|
|
Feb 15
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
1,661
+0.95%
|
-
|
|
Feb 15
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
707
-5.22%
|
$31,108
$44.01 P/Share
|
|
Feb 15
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,292
+8.7%
|
-
|
|
Feb 15
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
813
-29.36%
|
$35,772
$44.01 P/Share
|
|
Feb 15
2022
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
2,769
+50.0%
|
-
|
|
Feb 15
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
388
-1.92%
|
$17,072
$44.01 P/Share
|
|
Feb 15
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,108
+5.19%
|
-
|
|
Feb 15
2022
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-1.08%
|
$16,192
$44.01 P/Share
|
|
Feb 15
2022
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+3.41%
|
-
|
|
Feb 15
2022
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,038
-1.14%
|
$45,672
$44.01 P/Share
|
|
Feb 15
2022
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
1,846
+2.0%
|
-
|
|
Feb 08
2022
|
John Bradley Sorenson EVP, Global Operations |
SELL
Bona fide gift
|
Direct |
1,767
-5.12%
|
-
|
|
Feb 07
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Bona fide gift
|
Indirect |
1,390
+15.76%
|
-
|
|
Feb 07
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
2,780
-1.32%
|
-
|
|
Feb 07
2022
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
13,167
-27.61%
|
$566,181
$43.2 P/Share
|
|
Feb 01
2022
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
919
-2.89%
|
$39,517
$43.5 P/Share
|
|
Feb 01
2022
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,131
+8.97%
|
-
|
|
Jan 04
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
6,161
-100.0%
|
$264,923
$43.54 P/Share
|
|
Jan 04
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
6,840
-4.89%
|
$294,120
$43.54 P/Share
|
|
Jan 03
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Open market or private sale
|
Direct |
700
-5.49%
|
$29,400
$42.59 P/Share
|
|
Jan 01
2022
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,057
-1.47%
|
$170,394
$42.48 P/Share
|
|
Jan 01
2022
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,193
+4.56%
|
-
|
|
Jan 01
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
2,766
-8.66%
|
$116,172
$42.48 P/Share
|
|
Jan 01
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
6,175
+16.21%
|
-
|